Assessing The Sales Impact Of The New Health Insurance Exchange Market
Many stakeholders have an interest in how the new health insurance exchanges mandated by the Affordable Care Act will impact product sales. While a multitude of known and unknown factors impact health insurance coverage decisions, and subsequently which services and products and services get used, surprisingly robust actuarial models used in the insurance industry are very applicable to forecasting product sales.
You may also be interested in...
Most health reform watchers have been tracking state votes on Medicaid expansion as a sort of scorecard on whether Obama Administration is winning or losing in health care reform. Push back from the states is making news now, but for biopharma sponsors, even a glass half full is a positive—and the long-term outlook is even brighter.
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.